Mullen JT - Search Results

1

Regulation of herpes simplex virus 1 replication using tumor-associated promoters.

Mullen JT, Kasuya H, Yoon SS, Carroll NM, Pawlik TM, Chandrasekhar S, Nakamura H, Donahue JM, Tanabe KK. Mullen JT, et al. Ann Surg. 2002 Oct;236(4):502-12; discussion 512-3. doi: 10.1097/00000658-200210000-00013. Ann Surg. 2002. PMID: 12368679 Free PMC article.

2

Oncolysis of diffuse hepatocellular carcinoma by intravascular administration of a replication-competent, genetically engineered herpesvirus.

Pawlik TM, Nakamura H, Yoon SS, Mullen JT, Chandrasekhar S, Chiocca EA, Tanabe KK. Pawlik TM, et al. Among authors: mullen jt. Cancer Res. 2000 Jun 1;60(11):2790-5. Cancer Res. 2000. PMID: 10850415

3

Multimodality therapy with a replication-conditional herpes simplex virus 1 mutant that expresses yeast cytosine deaminase for intratumoral conversion of 5-fluorocytosine to 5-fluorouracil.

Nakamura H, Mullen JT, Chandrasekhar S, Pawlik TM, Yoon SS, Tanabe KK. Nakamura H, et al. Among authors: mullen jt. Cancer Res. 2001 Jul 15;61(14):5447-52. Cancer Res. 2001. PMID: 11454690

4

Regulation of herpes simplex virus gamma(1)34.5 expression and oncolysis of diffuse liver metastases by Myb34.5.

Nakamura H, Kasuya H, Mullen JT, Yoon SS, Pawlik TM, Chandrasekhar S, Donahue JM, Chiocca EA, Chung RY, Tanabe KK. Nakamura H, et al. Among authors: mullen jt. J Clin Invest. 2002 Apr;109(7):871-82. doi: 10.1172/JCI10623. J Clin Invest. 2002. PMID: 11927614 Free PMC article.

5

Viral oncolysis.

Mullen JT, Tanabe KK. Mullen JT, et al. Oncologist. 2002;7(2):106-19. doi: 10.1634/theoncologist.7-2-106. Oncologist. 2002. PMID: 11961194 Free article. Review.

6

Prodrug bioactivation and oncolysis of diffuse liver metastases by a herpes simplex virus 1 mutant that expresses the CYP2B1 transgene.

Pawlik TM, Nakamura H, Mullen JT, Kasuya H, Yoon SS, Chandrasekhar S, Chiocca EA, Tanabe KK. Pawlik TM, et al. Among authors: mullen jt. Cancer. 2002 Sep 1;95(5):1171-81. doi: 10.1002/cncr.10776. Cancer. 2002. PMID: 12209705 Free article.

7

Viral oncolysis.

Donahue JM, Mullen JT, Tanabe KK. Donahue JM, et al. Among authors: mullen jt. Surg Oncol Clin N Am. 2002 Jul;11(3):661-80. doi: 10.1016/s1055-3207(02)00025-x. Surg Oncol Clin N Am. 2002. PMID: 12487061 Review.

8

Viral oncolysis for malignant liver tumors.

Mullen JT, Tanabe KK. Mullen JT, et al. Ann Surg Oncol. 2003 Jul;10(6):596-605. doi: 10.1245/aso.2003.07.020. Ann Surg Oncol. 2003. PMID: 12839843 Review.

9

Selectivity of an oncolytic herpes simplex virus for cells expressing the DF3/MUC1 antigen.

Kasuya H, Pawlik TM, Mullen JT, Donahue JM, Nakamura H, Chandrasekhar S, Kawasaki H, Choi E, Tanabe KK. Kasuya H, et al. Among authors: mullen jt. Cancer Res. 2004 Apr 1;64(7):2561-7. doi: 10.1158/0008-5472.can-03-3431. Cancer Res. 2004. PMID: 15059912

10

Oncolysis by viral replication and inhibition of angiogenesis by a replication-conditional herpes simplex virus that expresses mouse endostatin.

Mullen JT, Donahue JM, Chandrasekhar S, Yoon SS, Liu W, Ellis LM, Nakamura H, Kasuya H, Pawlik TM, Tanabe KK. Mullen JT, et al. Cancer. 2004 Aug 15;101(4):869-77. doi: 10.1002/cncr.20434. Cancer. 2004. PMID: 15305421 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

197 results

Search Page